The Board of Directors in
The capital increase is expected to be registered within 7 days, and following the issuance of the new shares, the issued share capital of
-End-
Contacts
CEO,
ir@bergenbio.com
CFO,
rune.skeie@bergenbio.com
Forward looking statements
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
https://news.cision.com/bergenbio-asa/r/bergenbio-asa--increase-of-share-capital--exercise-of-share-options,c3493973
https://mb.cision.com/Main/15728/3493973/1526326.pdf
(c) 2022 Cision. All rights reserved., source